Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 398 results for "pfizer"

Pfizer Announces FDA Acceptance for Review of New Drug Applica...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. announced today that the United States Food and Drug Administration (FDA) accepted for review Pfizer's new drug application (NDA) for XELJANZ ® (tofacitinib citrate) 11 mg once daily modified release tablets ... CNBC, 1 hour ago
[x]  

1,014 images for pfizer

WKRB News, 1 hour ago
Ipswich Satellite, 1 day ago
SleekMoney, 3 days ago
Motley Fool, 10 minutes ago
NDTV Profit, 2 days ago
Examiner.com, 1 day ago
Xconomy, 7 hours ago
Motley Fool, 21 hours ago
Canberra Times, 21 hours ago
Estcourt and Midland News, 1 day ago
Motley Fool

1 Way Pfizer Continues to Stand Out From the Crowd

Source: Pfizer via Facebook. This decade hasn't been too kind to Big Pharma giant Pfizer ( NYSE:PFE ) despite what its stock price might show. Since 2010, Pfizer's revenue has been on a precipitous decline as a result of an unprecedented ...
 Motley Fool10 minutes ago Pfizer (PFE) Showing Bearish Technicals With Resistance At $34.10  Individual.com4 hours ago Pfizer Receives $37.47 Consensus Target Price from Brokerages (NYSE:PFE)  WKRB News1 hour ago Pfizer (PFE) Showing Resistance Near $34.01  Individual.com1 day ago
Xconomy

XRpro Re-Launching Icagen After Acquirin...

XRpro Sciences said today it acquired from Pfizer assets related to the ion channel biology platform that the pharma giant inherited by acquiring Icagen in 2011, as well as all of Pfizer's rights to the Icagen name and trademark. XRpro agreed to ...
 Genetic Engineering News13 minutes ago Company Update: Pfizer Inc (NYSE:PFE) Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D  BioSpace4 hours ago Four years after buyout, Pfizer spins Icagen ion channel platform back out  FierceBiotech5 hours ago XRpro Resurrects Icagen With Buy of Some Pfizer Ion Channel Assets  Xconomy7 hours ago
[x]  
This is Money

ViiV Healthcare inks manufacturing deal for production of dolutegravir in China

ViiV Healthcare , the joint venture between GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE), secures a manufacturing agreement with Shanghai-based Desano Pharmaceuticals for the production of dolutegravir in China. The deal provides an additional ...
 Seeking Alpha9 hours ago ViiV Healthcare and China's Desano sign manufacturing deal for new HIV drug Tivicay  Pharmaceutical Technology9 hours ago China's Desano Pharma to Make API for New HIV Drug for ViiV  Financial Content28 minutes ago Relations between GlaxoSmithKline and China thawing as drug maker announces deal to make HIV medicine with Shanghai firm Desano  This is Money50 minutes ago
India Infoline

Pfizer shifts its registered office

Pfizer has informed that the Registrar and Transfer Agent of the Company, i.e. Karvy Computershare Private Limited have changed their registered office address to 'Karvy Selenium Tower B, Plot No 31 32 Gachibowli, Financial District, Nanakramguda, ...
 Money Control5 hours ago Pfizer announces change in directorate  Business Standard3 weeks ago Pfizer: Aijaz Tobaccowalla to continue as MD until successor appointed  India Infoline3 weeks ago Pfizer announces change in CFO  Business Standard1 month ago

Pfizer (PFE) Is Today's Water-Logged And Getting Wetter Stock

Reddit Email Reprint Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Pfizer ( PFE ...
 TheStreet.com4 hours ago
ACQ Magazine

Vaccines Are Emerging As Pfizer's USP

Pfizer recently announced its decision to acquire two meningitis vaccines, Nimenrix and Mencevax, from GlaxoSmithKline for $130 million. Both vaccines are approved for commercial sales and the move builds upon Pfizer's last year's acquisition of ...
 Forbes.com9 hours ago GSK sells two vaccines to Pfizer to ease competition concerns  Reuters1 week ago

Northstar Tech Center welcomes first tenant [The Press-Republican, Plattsburgh, N.Y.]

July 01--CHAZY -- Quebec-based Plastitel Plastics is the first tenant at Northstar Technology Center, the former Pfizer facility in the Town of Chazy. On Wednesday, Plastitel Plastics President Normand Lucier thanked Stephen and Victor Podd, the ...
 Bloomberg23 hours ago 07/01/2015: Empire State Development Announces New Life For Former Pfizer Facility After 6 Years of Vacancy  Noodls1 day ago
Sys-Con Media

Critical Alerts For Invensense, Pfizer Inc., The Hartford Financial Services Group Inc., The Chubb Corporation and AutoZone Inc. Released By InvestorsObserver

To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note: You may have to copy this link into your browser then press the [ENTER] key.) INVN: ...
 Wall Street Select8 hours ago
[x]  
Arabstoday.net

Can't argue with the numbers

Pfizer Australia Chairman and Managing Director David Gallagher at the Senate inquiry into corporate tax avoidance. Photo: Daniel Munoz COMMENT It is a rare moment to find harmony and political consensus in Australian politics, but when big ...
 WA Today1 day ago Global pharma firms grilled about tax …  Yahoo! India1 day ago Pharma firms grilled about tax in Australia  DAWN Group19 hours ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less